Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$288K Buy
8,080
+1,795
+29% +$69K 0.01% 732
2019
Q2
$271K Buy
6,285
+2,958
+89% +$123K 0.01% 748
2019
Q1
$146K Hold
3,327
﹤0.01% 860
2018
Q4
$120K Sell
3,327
-2,852
-46% -$106K ﹤0.01% 864
2018
Q3
$248K Buy
6,179
+317
+5% +$12.7K 0.01% 794
2018
Q2
$225K Hold
5,862
0.01% 753
2018
Q1
$201K Hold
5,862
0.01% 789
2017
Q4
$192K Hold
5,862
0.01% 797
2017
Q3
$196K Hold
5,862
0.01% 742
2017
Q2
$208K Hold
5,862
0.01% 678
2017
Q1
$180K Buy
5,862
+14
+0.2% +$432 0.01% 608
2016
Q4
$180K Buy
+5,848
New +$174K 0.01% 591

Other funds holding QGEN

Elkfork Partners's QGEN Position: Q3 2019 in Review

Elkfork Partners increased its Qiagen (QGEN) stake by 29% in Q3 2019, buying an estimated $69K and bringing the position to 8,080 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #732.

Elkfork Partners first reported a position in QGEN in Q4 2016 and has held it in 12 quarters since. 244 funds tracked by Wall St. Rank hold QGEN as of Q3 2019.

  • Elkfork Partners held 8,080 shares of Qiagen worth $288K as of Q3 2019.
  • Elkfork Partners bought 1,795 Qiagen shares in Q3 2019, an estimated $69K.
  • Qiagen made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #732 holding.
  • Elkfork Partners first reported a position in Qiagen in Q4 2016 and has held it in 12 quarters since.
  • 244 funds tracked by Wall St. Rank held Qiagen as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.